131 related articles for article (PubMed ID: 14983813)
1. Labeling changes for asthma drug salmeterol.
FDA Consum; 2003; 37(6):6. PubMed ID: 14983813
[No Abstract] [Full Text] [Related]
2. Fluticasone/salmeterol: labeling change.
Prescrire Int; 2008 Dec; 17(98):229. PubMed ID: 19418648
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol for the treatment of asthma.
Weinberger M
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
[No Abstract] [Full Text] [Related]
4. Salmeterol.
Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139
[No Abstract] [Full Text] [Related]
5. Salmeterol and paroxetine: more evidence for paradoxical medicine.
Yun AJ; Lee PY; Doux JD
Med Hypotheses; 2006; 66(5):1037-8. PubMed ID: 16364562
[No Abstract] [Full Text] [Related]
6. Evidence based answers--is salmeterol safe in asthma?
Spurling G; Doust J
Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
[No Abstract] [Full Text] [Related]
7. Misleading data analyses in salmeterol (SMART) study.
Lurie P; Wolfe SM
Lancet; 2005 Oct; 366(9493):1261-2; discussion 1262. PubMed ID: 16214589
[No Abstract] [Full Text] [Related]
8. [A new long-acting asthma spray. Preliminary wait-and-see attitude?].
Flaten O
Tidsskr Nor Laegeforen; 1993 May; 113(13):1610. PubMed ID: 8101664
[No Abstract] [Full Text] [Related]
9. Excess mortality in patients with asthma on long-acting beta2-agonists.
Hasford J; Virchow JC
Eur Respir J; 2006 Nov; 28(5):900-2. PubMed ID: 17074917
[No Abstract] [Full Text] [Related]
10. Drug safety and salmeterol: the controversy continues.
Weiss KB
Ann Intern Med; 2008 Jul; 149(1):56-7. PubMed ID: 18523131
[No Abstract] [Full Text] [Related]
11. Can beta agonists cause dilated cardiomyopathy?
Choudhary AS; Robinson GM
Heart Lung Circ; 2009 Oct; 18(5):367-9. PubMed ID: 19081299
[TBL] [Abstract][Full Text] [Related]
12. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
Prescrire Int; 2007 Dec; 16(92):257-8. PubMed ID: 18092426
[No Abstract] [Full Text] [Related]
13. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].
Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H
Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125
[No Abstract] [Full Text] [Related]
14. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
15. Is salmeterol safe in asthma?
Subramanian S; Kumaravel A
Aust Fam Physician; 2006 Dec; 35(12):936. PubMed ID: 17201021
[No Abstract] [Full Text] [Related]
16. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
17. [More asthma death cases with beta-2-antagonists: with inhaled corticosteroids on the safe side?].
Wepner U
MMW Fortschr Med; 2007 Dec; 149(49-50):20. PubMed ID: 18240436
[No Abstract] [Full Text] [Related]
18. [Salmeterol-induced enuresis in children].
Lakartidningen; 1996 May; 93(21):2083. PubMed ID: 8649105
[No Abstract] [Full Text] [Related]
19. Levalbuterol and racemic albuterol: are there therapeutic differences?
Ahrens R; Weinberger M
J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
[No Abstract] [Full Text] [Related]
20. Can oral beta2 agonists cause heart failure?
Jenne JW
Lancet; 1998 Oct; 352(9134):1081-2. PubMed ID: 9798578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
